Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer
Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n = 67) and APR (n = 109) for low...
Saved in:
Published in | Korean journal of clinical oncology Vol. 17; no. 2; pp. 73 - 81 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
대한종양외과학회
01.12.2021
Korean Society of Surgical Oncology |
Subjects | |
Online Access | Get full text |
ISSN | 1738-8082 2288-4084 2288-4084 |
DOI | 10.14216/kjco.21012 |
Cover
Abstract | Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n = 67) and APR (n = 109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.Results: With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P = 0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P = 0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P < 0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P < 0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P = 0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P = 0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P = 0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P < 0.005).Conclusion: Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. |
---|---|
AbstractList | Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.
Methods: Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.
Results: With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005).
Conclusion: Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. KCI Citation Count: 0 The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer. Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database. With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005). Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. Purpose The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer. Methods Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database. Results With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1–2) was an independent prognostic factor for DFS (P<0.005). Conclusion Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.PurposeThe present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low lying rectal cancer.Between January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.MethodsBetween January 2001 and December 2014, 176 patients who underwent SSR (n=67) and APR (n=109) for low rectal cancer, without stage IV, were retrieved from a retrospective database.With a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005).ResultsWith a median follow-up of 66.5 months. The mean total number of harvested lymph nodes was 16.7 (SSR) versus 17.1 (APR) (P=0.801). The advanced T stage was higher in the APR group (82.6%) versus the SSR group (55.2%) (P=0.006). The positive rate of lymph nodes after surgery was significantly higher in the APR group (45.9%) versus SSR group (25.4%) (P<0.05). The 5-year overall survival rates for SSR and APR were 87.3% and 67.6%, respectively (P<0.005). The 5-year disease-free survival rate (DFS) was 83.6% (SSR) versus 65.5% (APR) (P=0.002). The recurrence rate was higher in the APR group (34.9%) versus the SSR group (14.9%) (P=0.004). Local recurrence rate was not different between the two groups. However, distant recurrence rate was significantly higher in the APR group (26.6% vs. 11.9%, P=0.023). In multivariate analysis, node positive (N0 vs. N1-2) was an independent prognostic factor for DFS (P<0.005).Based on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group.ConclusionBased on the present data, SSR achieved better 5-year oncological outcome than APR. The positive lymph node ratio in the N stage after surgery was higher in the APR group and this seems to have an effect on the oncological outcomes of the APR group. |
Author | Dae Ro Lim Won Il Jo Jung Cheol Kuk Eung Jin Shin |
Author_xml | – sequence: 1 givenname: Won Il surname: Jo fullname: Jo, Won Il – sequence: 2 givenname: Dae Ro orcidid: 0000-0002-3076-1391 surname: Lim fullname: Lim, Dae Ro – sequence: 3 givenname: Jung Cheol surname: Kuk fullname: Kuk, Jung Cheol – sequence: 4 givenname: Eung Jin surname: Shin fullname: Shin, Eung Jin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36945671$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002801296$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kt1rFDEQwBep2LP2yXfZF0GRq_naTfIilLPqQbEg9Tlks5Nr7naTa7J7UvznzX14tIJPgclvfjOZzMvixAcPRfEaowvMCK4_rpYmXBCMMHlWTAgRYsqQYCfFBHMqpgIJclqcp7RECBFJKKb1i-KU1pJVNceT4vcs9GsdXQq-DLYM3oQuLJwpwziY0MM2qJs29M6HNUTnQXdlhARmcDllAzGNqUzrO-fNALFMeuP84hFhQyy78KvsHvZxM2SB0d5AfFU8t7pLcH44z4qfX65uZ9-m1zdf57PL66mhVU2mlW2AUKFJjbkQAgE0xhKEOCGGWqxbjVkrK9CcmLYVBipLZCtbBqRpcH7zWfF-7_XRqpVxKmi3OxdBraK6_HE7V1IKRDnK7HzPtkEv1Tq6XseHXcIuEOJC6Tg404Fq8tBFI6SwDWGMaVFTwaioKgm8tRVk16e9az02PbQG_BB190T69Ma7u9zTJjfDCK9oFrw7CGK4HyENqnfJQNdpD2FMinAhOUYVlxl987jWscjfn87Ahz1gYkgpgj0iGKndKqntKqndKmUa_0MbN-jth-ZGXfefnLeHMY_ZDK3TxxLfbz5fYYw5EbWgfwAbO9to |
CitedBy_id | crossref_primary_10_1007_s00053_024_00834_5 crossref_primary_10_1245_s10434_024_16316_3 |
Cites_doi | 10.1007/s00384-012-1590-8 10.1007/bf02307027 10.1007/s10434-001-0163-9 10.1155/2017/6058907 10.1055/s-2007-984865 10.1016/s0360-3016(01)02643-8 10.1097/00000658-200204000-00001 10.1002/bjs.1800810944 10.1007/s11605-010-1165-3 10.1007/s00384-017-2755-2 10.1056/nejmoa060829 10.1200/jco.2009.22.0467 10.1097/md.0000000000008249 10.1002/jso.26249 10.1136/gut.2010.211557 10.1245/s10434-014-3573-1 10.1007/s00464-013-3014-4 10.1200/jco.2007.12.7027 10.1200/jco.2007.15.3858 10.1097/sla.0b013e318195e17c 10.1007/s10350-003-0012-y 10.1136/jclinpath-2018-205592 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Korean Society of Surgical Oncology. Copyright © 2021 Korean Society of Surgical Oncology 2021 |
Copyright_xml | – notice: Copyright © 2021 Korean Society of Surgical Oncology. – notice: Copyright © 2021 Korean Society of Surgical Oncology 2021 |
DBID | DBRKI TDB AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.14216/kjco.21012 |
DatabaseName | DBPIA - 디비피아 Nurimedia DBPIA Journals CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2288-4084 |
EndPage | 81 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9980370 oai_doaj_org_article_b1018b898fb2444a8638438559e7df5e PMC9942753 36945671 10_14216_kjco_21012 NODE11172868 |
Genre | Journal Article |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DBRKI GROUPED_DOAJ GW5 PGMZT RPM TDB AAYXX CITATION NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c3562-5fbe238a26178880eebcf200722c3f1ada14d95ea72cdd8ce5f29d9d4e2bb1923 |
IEDL.DBID | DOA |
ISSN | 1738-8082 2288-4084 |
IngestDate | Thu Dec 19 03:18:36 EST 2024 Wed Aug 27 01:28:48 EDT 2025 Thu Aug 21 18:37:29 EDT 2025 Fri Jul 11 07:30:47 EDT 2025 Thu Jan 02 22:53:06 EST 2025 Tue Jul 01 02:40:47 EDT 2025 Thu Apr 24 23:00:51 EDT 2025 Thu Feb 06 13:25:20 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Rectal neoplasms Surgery Abdominoperineal resection |
Language | English |
License | Copyright © 2021 Korean Society of Surgical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3562-5fbe238a26178880eebcf200722c3f1ada14d95ea72cdd8ce5f29d9d4e2bb1923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://doi.org/10.14216/kjco.21012 |
ORCID | 0000-0002-3076-1391 |
OpenAccessLink | https://doaj.org/article/b1018b898fb2444a8638438559e7df5e |
PMID | 36945671 |
PQID | 2789710579 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9980370 doaj_primary_oai_doaj_org_article_b1018b898fb2444a8638438559e7df5e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9942753 proquest_miscellaneous_2789710579 pubmed_primary_36945671 crossref_primary_10_14216_kjco_21012 crossref_citationtrail_10_14216_kjco_21012 nurimedia_primary_NODE11172868 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20211201 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 20211201 day: 1 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean journal of clinical oncology |
PublicationTitleAlternate | Korean J Clin Oncol |
PublicationYear | 2021 |
Publisher | 대한종양외과학회 Korean Society of Surgical Oncology |
Publisher_xml | – name: 대한종양외과학회 – name: Korean Society of Surgical Oncology |
References | ref12 ref15 ref14 Rullier (ref2) 2005 ref11 ref10 ref1 Marr (ref9) 2005 ref17 ref16 Warwick (ref19) 1973 ref18 Saito (ref7) 2006 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref27 ref8 Mezhir (ref13) 2012 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref18 doi: 10.1007/s00384-012-1590-8 – ident: ref6 doi: 10.1007/bf02307027 – ident: ref12 doi: 10.1007/s10434-001-0163-9 – ident: ref15 doi: 10.1155/2017/6058907 – ident: ref14 doi: 10.1055/s-2007-984865 – ident: ref25 doi: 10.1016/s0360-3016(01)02643-8 – ident: ref26 doi: 10.1097/00000658-200204000-00001 – ident: ref1 doi: 10.1002/bjs.1800810944 – ident: ref11 doi: 10.1007/s11605-010-1165-3 – ident: ref27 doi: 10.1007/s00384-017-2755-2 – start-page: S13 volume-title: Intersphincteric resection in patients with very low rectal cancer: a review of the Japanese experience year: 2006 ident: ref7 – ident: ref24 doi: 10.1056/nejmoa060829 – ident: ref4 doi: 10.1200/jco.2009.22.0467 – ident: ref17 doi: 10.1097/md.0000000000008249 – ident: ref16 doi: 10.1002/jso.26249 – ident: ref20 doi: 10.1136/gut.2010.211557 – ident: ref8 doi: 10.1245/s10434-014-3573-1 – start-page: 706 volume-title: Angiology year: 1973 ident: ref19 – start-page: 74 volume-title: The modern abdominoperineal excision: the next challenge after total mesorectal excision year: 2005 ident: ref9 – start-page: 465 volume-title: Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule year: 2005 ident: ref2 – ident: ref3 doi: 10.1007/s00464-013-3014-4 – start-page: 274 volume-title: Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome year: 2012 ident: ref13 – ident: ref21 doi: 10.1200/jco.2007.12.7027 – ident: ref23 doi: 10.1200/jco.2007.15.3858 – ident: ref22 doi: 10.1097/sla.0b013e318195e17c – ident: ref10 doi: 10.1007/s10350-003-0012-y – ident: ref5 doi: 10.1136/jclinpath-2018-205592 |
SSID | ssj0002923136 ssib059951131 |
Score | 2.1659267 |
Snippet | Purpose: The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR)... The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR) for low... Purpose The present study compares the peri/postoperative and oncological outcomes of abdominoperineal resections (APR) and sphincter saving resection (SSR)... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref nurimedia |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 73 |
SubjectTerms | abdominoperineal resection Original rectal neoplasms surgery 일반외과학 |
Title | Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer |
URI | https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE11172868 https://www.ncbi.nlm.nih.gov/pubmed/36945671 https://www.proquest.com/docview/2789710579 https://pubmed.ncbi.nlm.nih.gov/PMC9942753 https://doaj.org/article/b1018b898fb2444a8638438559e7df5e https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002801296 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 대한종양외과학회지, 2021, 17(2), , pp.73-81 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQXuCCQLzCozJoT0hhE8eJ7SMsXS1Iu1xYaW9W_GJLu3HVhxBC4rcz42SjFq3EhUurum6qeD57vnE83xByWIRCGcl57qSDAMVZmcs2qNzW3vuqDpynDLmz8-b0gn--rC93Sn3hmbBeHrgfuCODklJGKhkMeCLeSgAMryQQYS9cqD2uvoUqdoIpQBKqaJXl8HwL12SGPCbVCywFzHAJjm9I1uOsbI7m3218x1Dqas89JRV_cDrdCj7c7bYouA9Wu42M_n2mcsdJnTwg9wd2Sd_3d_WQ3PHdI_LreKw1SGOgsbP9gkfjdgN489jYGhevZ11cpmxAuARmJaWUB4rnNrZrul5ezTpUdqbrFjchdnoA76WL-IMufvbtFgg9tQin1WNycTL9enyaDzUXclsBFcrrYDx48RaF2iE4Lrw3NuB-JmO2CmXr2pI7VftWMOuctL4OTDnluGfGIFt8Qg662PlnhAZlKqMM8AkbuHeNEQoMWTfSCIcqQhl5ezPU2g6C5FgXY6ExMEG7aLSLTnbJyOHYednrcNze7QPabOyC4tmpASClB0jpf0EqI2_A4npuZ-n3-P4t6vlKQ4jxSUN8WlSiyMhkBMT4d-dfPk7BeQgmG5mR1zco0TBl8TlM2_m4XWtMPhZYX1ll5GmPmvEKVaOA0ooyI2IPT3t3tP9NN7tKsuBKcQbB5_P_MQQvyD2Gh3fSuZ2X5GCz2vpXwL42ZpImGrye_Z5O0ubYH4nMLws |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+oncologic+outcome+of+abdominoperineal+resection+versus+sphincter+saving+resection+for+low+lying+rectal+cancer&rft.jtitle=Korean+journal+of+clinical+oncology&rft.au=Jo%2C+Won+Il&rft.au=Lim%2C+Dae+Ro&rft.au=Kuk%2C+Jung+Cheol&rft.au=Shin%2C+Eung+Jin&rft.date=2021-12-01&rft.pub=Korean+Society+of+Surgical+Oncology&rft.issn=1738-8082&rft.eissn=2288-4084&rft.volume=17&rft.issue=2&rft.spage=73&rft.epage=81&rft_id=info:doi/10.14216%2Fkjco.21012&rft.externalDocID=PMC9942753 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-8082&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-8082&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-8082&client=summon |